[Therapy and differential therapy with beta sympathicolytic drugs].
D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000526:Alprenolol / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy; D001145:Arrhythmias, Cardiac / Q000188:drug therapy; D002312:Cardiomyopathy, Hypertrophic / Q000188:drug therapy; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004347:Drug Interactions; D004983:Ethanolamines / Q000627:therapeutic use; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008134:Long-Term Care; D010096:Oxprenolol / Q000627:therapeutic use; D010869:Pindolol / Q000627:therapeutic use; D011412:Propanolamines / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D013577:Syndrome; D013610:Tachycardia / Q000188:drug therapy
D000319:Adrenergic beta-Antagonists; D004071:Digitalis Glycosides; D004983:Ethanolamines; D011412:Propanolamines; D010096:Oxprenolol; D000526:Alprenolol; D011433:Propranolol; D010869:Pindolol
Therapie und Differentialtherapie mit betasympathikolytischen Medikamenten